Sanfilippo Syndrome Type A
Pipeline by Development Stage
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (13)
Total enrollment: 1,602 patients across 13 trials
An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Taste Assessment Study of SHP429 in Healthy Adult Subjects
Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
Assessment of Updated Educational Materials for Instanyl®
Wearable Assessments in the Clinic and Home in PD
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
Neurobehavioral Phenotypes in MPS III
Sophisticated Assessment of Disease Burden in Patients With Fabry Disease
A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)
Screening Study to Identify Pediatric Patients With Hunter Syndrome Who Demonstrate Evidence of Central Nervous System (CNS) Involvement and Who Are Currently Receiving Treatment With Elaprase®
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.